vs
Side-by-side financial comparison of GILAT SATELLITE NETWORKS LTD (GILT) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
GILAT SATELLITE NETWORKS LTD is the larger business by last-quarter revenue ($152.7M vs $151.7M, roughly 1.0× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 4.1%, a 3.7% gap on every dollar of revenue.
Gilat Satellite Networks Ltd. is an Israeli public company. It provides satellite-based broadband communications technology, its main expertise being the development, manufacture, and marketing of ground-based satellite systems for global communication via satellites.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
GILT vs NUTX — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $152.7M | $151.7M |
| Net Profit | $6.3M | $11.8M |
| Gross Margin | 35.8% | 30.4% |
| Operating Margin | 5.4% | 20.4% |
| Net Margin | 4.1% | 7.8% |
| Revenue YoY | — | -41.1% |
| Net Profit YoY | — | -80.8% |
| EPS (diluted) | $57016808.00 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $151.7M | ||
| Q3 25 | — | $267.8M | ||
| Q2 25 | $152.7M | $244.0M | ||
| Q1 25 | — | $211.8M | ||
| Q4 24 | — | $257.6M | ||
| Q3 24 | — | $78.8M | ||
| Q2 24 | $126.6M | $76.1M | ||
| Q1 24 | — | $67.5M |
| Q4 25 | — | $11.8M | ||
| Q3 25 | — | $55.4M | ||
| Q2 25 | $6.3M | $-17.7M | ||
| Q1 25 | — | $21.2M | ||
| Q4 24 | — | $61.6M | ||
| Q3 24 | — | $-8.8M | ||
| Q2 24 | $9.9M | $-364.0K | ||
| Q1 24 | — | $-364.0K |
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | 35.8% | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | 39.7% | 29.7% | ||
| Q1 24 | — | 15.1% |
| Q4 25 | — | 20.4% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | 5.4% | 13.8% | ||
| Q1 25 | — | 38.1% | ||
| Q4 24 | — | 44.4% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | 9.8% | 7.0% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | — | 7.8% | ||
| Q3 25 | — | 20.7% | ||
| Q2 25 | 4.1% | -7.3% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | — | 23.9% | ||
| Q3 24 | — | -11.2% | ||
| Q2 24 | 7.8% | -0.5% | ||
| Q1 24 | — | -0.5% |
| Q4 25 | — | $2.34 | ||
| Q3 25 | — | $7.76 | ||
| Q2 25 | $57016808.00 | $-2.95 | ||
| Q1 25 | — | $3.33 | ||
| Q4 24 | — | $11.56 | ||
| Q3 24 | — | $-1.72 | ||
| Q2 24 | $56622204.00 | $-0.07 | ||
| Q1 24 | — | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $64.9M | $185.6M |
| Total DebtLower is stronger | $56.5M | — |
| Stockholders' EquityBook value | $315.8M | $329.4M |
| Total Assets | $575.9M | $918.5M |
| Debt / EquityLower = less leverage | 0.18× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $185.6M | ||
| Q3 25 | — | $166.0M | ||
| Q2 25 | $64.9M | $96.7M | ||
| Q1 25 | — | $84.7M | ||
| Q4 24 | — | $40.6M | ||
| Q3 24 | — | $46.9M | ||
| Q2 24 | $93.7M | $40.8M | ||
| Q1 24 | — | $30.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $56.5M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $2.0M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $329.4M | ||
| Q3 25 | — | $317.2M | ||
| Q2 25 | $315.8M | $235.3M | ||
| Q1 25 | — | $176.9M | ||
| Q4 24 | — | $132.4M | ||
| Q3 24 | — | $60.4M | ||
| Q2 24 | $282.8M | $62.7M | ||
| Q1 24 | — | $63.0M |
| Q4 25 | — | $918.5M | ||
| Q3 25 | — | $964.5M | ||
| Q2 25 | $575.9M | $841.0M | ||
| Q1 25 | — | $761.9M | ||
| Q4 24 | — | $655.3M | ||
| Q3 24 | — | $438.5M | ||
| Q2 24 | $416.9M | $422.4M | ||
| Q1 24 | — | $404.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $70.4M | ||
| Q3 25 | — | $99.5M | ||
| Q2 25 | — | $27.3M | ||
| Q1 25 | — | $51.0M | ||
| Q4 24 | — | $54.0K | ||
| Q3 24 | — | $6.8M | ||
| Q2 24 | $8.2M | $13.3M | ||
| Q1 24 | — | $3.1M |
| Q4 25 | — | $69.0M | ||
| Q3 25 | — | $99.2M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $50.9M | ||
| Q4 24 | — | $-341.0K | ||
| Q3 24 | — | $6.2M | ||
| Q2 24 | $1.7M | $12.7M | ||
| Q1 24 | — | $2.3M |
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | 24.0% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | 1.3% | 16.7% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | 5.2% | 0.7% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | — | 5.95× | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GILT
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
